. 2021 Sep 27;8:713652. doi: 10.3389/fcvm.2021.713652
Copyright © 2021 Russo, Viazzi, Pontremoli, Barbagallo, Bombelli, Casiglia, Cicero, Cirillo, Cirillo, Desideri, D'Elia, Dell'Oro, Ferri, Galletti, Gesualdo, Giannattasio, Iaccarino, Leoncini, Mallamaci, Maloberti, Masi, Mengozzi, Mazza, Muiesan, Nazzaro, Palatini, Parati, Rattazzi, Rivasi, Salvetti, Tikhonoff, Tocci, Quarti Trevano, Ungar, Verdecchia, Virdis, Volpe, Grassi and Borghi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Figure 2.
Survival without cardiovascular (A) and all-cause mortality (B) on the basis of eGFR strata and presence/absence of hyperuricemia.